On the morning of August 17, 2025, Comrade Zhang Jiming, Secretary of the Lixin County Party Committee, led a delegation to conduct a thematic inspection of the preparation progress for the 18th National Cattle Industry Development Conference. The delegation included County CPPCC Chairman Shao Lifeng, Standing Committee Member and Executive Deputy County Governor Jiao Peng, and Standing Committee Member, Minister of Propaganda, and Director of the County Party Committee Office Li Lin. The delegation visited the GENOMBIO Life Health Industrial Park [GENOMBIO Biomedical Technology (Anhui) Co., Ltd.] located in the Lixin Economic Development Zone. GENOMBIO Chairman and CEO Dr. Liang Li, Group Vice President and R&D Center General Manager Dr. Yu Baoli, and Group Vice President and Head of Organoid Business Division Dr. Rong Luo warmly received the delegation, highlighting the company’s core products and R&D achievements. Secretary Zhang commended GENOMBIO’s explorations and innovations in the field of biomedicine and emphasized the importance of leveraging the Cattle Industry Conference to drive high-quality development of the cattle industry chain.
Focus on Core Products: Bovine-Derived Bioproducts Empowering High-Quality Cattle Industry
During the visit, Dr. Liang Li provided Secretary Zhang with a detailed introduction to GENOMBIO’s business layout and its core products closely linked to the cattle industry—bovine serum, albumin, hemoglobin, and other bovine-derived bioproducts. As critical raw materials for global life sciences research and biopharmaceutical production, GENOMBIO’s bovine bioproducts series, renowned for high purity, low endotoxin levels, and consistent quality, are widely applied in cell culture, vaccine development, diagnostic reagents, and more. These products not only enable high-value utilization of bovine biological resources but also provide key technological support for extending the cattle industry into high-value fields such as biomedicine.
Dr. Liang Li stated, “For 23 years, GENOMBIO has been committed to advancing the efficiency of bovine resource utilization through technological innovation. Our bovine-derived bioproducts series represents a crucial component in serving the life health industry chain and offers new pathways for the cattle industry to achieve diversified development.”
Science and Technology Empowerment: Building a New Ecosystem for High-Quality Cattle Industry Development
After listening to the introduction and conducting an on-site inspection, Secretary Zhang highly praised GENOMBIO’s R&D capabilities and industrial contributions. He emphasized that the Cattle Industry Conference serves as a vital platform to showcase achievements in Lixin’s modern cattle industry chain. Enterprises must leverage their strengths to actively participate in the conference, providing innovative case studies for industry transformation. He also urged relevant departments to continuously optimize the business environment, support enterprises in R&D and market expansion, and promote coordinated development across the industrial chain.
Notably, the 18th National Cattle Industry Development Conference will be held from August 28–30. GENOMBIO will showcase its core bovine-derived bioproducts and demonstrate the vast application prospects of bovine biological resources in biomedicine through technical exchanges and industrial collaboration, injecting strong technological momentum into the cattle industry’s transformation.
GENOMBIO: Guarding Life Health with Cell Technology
As a National High-Tech Enterprise, GENOMBIO focuses on the cell technology industry chain, covering seed cell banks, cell culture reagents and consumables, cell storage, cell therapy drug development, stem cell exosome applications, laboratory services, organoid products, and technical solutions. The company is dedicated to becoming a leading brand in the cell industry's entire industrial chain. By participating in the Cattle Industry Conference, GENOMBIO not only highlights its technical advantages in bovine-derived bioproducts but also embodies its mission of "Guarding Life Health with Cell Technology," providing robust scientific support for the high-quality development of the cattle industry’s entire value chain.